NEWS ROOM
- 2022.10.03【ARCALIS】Construction plan of mRNA therapeutics and vaccine production facility has been adopted for “Biopharmaceutical Production Base Development Project for Strengthening the Vaccine Production System” by the Ministry of Economy, Trade and Industry Press Release
- 2022.08.25Notice concerning Discussions between Meiji Seika Pharma and Arcalis, Regarding the Production and Supply of “ARCT-154” for Replicon Vaccine for COVID-19 Press Release
- 2022.07.20ARCALIS and Axcelead DDP Announce Collaboration to Provide Integrated Drug Discovery Support Service for mRNA Therapeutics Press Release
- 2022.06.29Notice of Transition to a Company with an Audit and Supervisory Committee and Appointment of the Members of the Board of Directors Press Release
- 2022.02.01Axcelead Begins Joint Research with Tokyo Medical and Dental University on mRNA Drug Development for Acute Cerebral Infarction and Postresuscitation Encephalopathy Press Release